Effects of Amyloid Precursor Protein 17 Peptide on the Protection of Diabetic Encephalopathy and Improvement of Glycol Metabolism in the Diabetic Rat
Researchers have proposed that amyloid precursor protein 17 peptide (APP17 peptide), an active fragment of amyloid precursor protein (APP) in the nervous system, has therapeutic effects on neurodegeneration. Diabetic encephalopathy (DE) is a neurological disease caused by diabetes. Here we use multi...
Main Authors: | Heng Meng, Duo Zhang, Haishan Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2013/689841 |
Similar Items
-
Insulin protects against amyloid β-peptide toxicity in brain mitochondria of diabetic rats
by: Paula I. Moreira, et al.
Published: (2005-04-01) -
Role of the Insulin-Like Growth Factor Type 1 Receptor in the Pathogenesis of Diabetic Encephalopathy
by: Duo Zhang, et al.
Published: (2015-01-01) -
Analysis of Metabolic Alterations Related to Pathogenic Process of Diabetic Encephalopathy Rats
by: Minjian Dong, et al.
Published: (2019-01-01) -
Reducing amyloid beta peptide production through regulation of amyloid precursor protein dimerization
by: Meguerian, Arman
Published: (2016) -
Diabetic encephalopathy
by: I. A. Strokov, et al.
Published: (2014-01-01)